Cargando…
Identification and characterization of blocking nanobodies against human CD70: Identification and characterization of blocking nanobodies
CD70 is overexpressed in a variety of solid and hematological tumors and plays a role in tumor proliferation and evasion of immune surveillance. Targeting and blocking its binding to the receptor CD27 have the potential to treat CD70-dependent tumors. To generate novel CD70 blocking agents, we scree...
Autores principales: | Zhang, Xin, Liu, Chang, Xie, Yuan, Hu, Qianqian, Chen, Yuanyuan, Li, Jiangwei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9827822/ https://www.ncbi.nlm.nih.gov/pubmed/36239354 http://dx.doi.org/10.3724/abbs.2022141 |
Ejemplares similares
-
Generation of a CD70-Specific Fusion Nanobody with IgG Recruiting Capacity for Tumor Killing
por: Liu, Chang, et al.
Publicado: (2023) -
Identification and Characterization of Specific Nanobodies against Trop-2 for Tumor Targeting
por: Hu, Yaozhong, et al.
Publicado: (2022) -
Identification and in vivo characterization of a brain-penetrating nanobody
por: Wouters, Y, et al.
Publicado: (2020) -
Nanobodies against Pfs230 block Plasmodium falciparum transmission
por: Dietrich, Melanie H., et al.
Publicado: (2022) -
Identification and characterization of Nanobodies targeting the EphA4 receptor
por: Schoonaert, Lies, et al.
Publicado: (2017)